Search Treatments A to Z
Search Treatments A to Z
Prostate cancer remains one of the most common malignancies affecting men worldwide. Over the last 50 years, significant advancements in research and technology have revolutionized the landscape of prostate cancer treatment. In the 1970s, options were limited primarily to radical prostatectomy and external beam radiation therapy, often with a standardized approach that did not account
Recent discussions among urologists suggest that rebranding low-grade prostate cancer could alleviate the anxiety patients experience upon diagnosis. Prostate cancer, notably common among men, often presents in low-grade forms that are typically slow-growing and unlikely to lead to severe health issues. This initiative aims to reduce overtreatment stemming from the fear associated with the “cancer”
New Genetic Factor Driving Prostate Cancer Recent research has identified a critical genetic factor that could change the way we understand and treat prostate cancer. Scientists have pinpointed a gene named NRF2 as a major driver in the development and progression of this disease. What is NRF2? NRF2 (Nuclear factor erythroid 2-related factor 2) is
Alchemilla, commonly known as lady’s mantle, encompasses numerous species distributed across Europe, Asia, and North America. Historically, Alchemilla has been utilized in traditional medicine for its purported health benefits, including its effects on prostate health and urinary function. Despite its long-standing traditional use, scientific research on Alchemilla’s effects on prostate health is relatively limited. However, recent interest in natural remedies for prostate-related issues has sparked renewed attention toward this botanical.